Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Diethylcarbamazine salt in the control of lymphatic filariasis.

Identifieur interne : 00C856 ( Main/Exploration ); précédent : 00C855; suivant : 00C857

Diethylcarbamazine salt in the control of lymphatic filariasis.

Auteurs : H. Gelband

Source :

RBID : pubmed:8024057

Descripteurs français

English descriptors

Abstract

Where lymphatic filariasis has diminished since about the 1950s, it has most frequently, though not always, been a direct result of chemotherapeutic intervention against the parasite. Diethylcarbamazine (DEC), a well-established drug, has been the single agent of chemotherapeutic control and has been successful in a wide variety of regimens. This paper reviews the experience with one strategy: long-term, low-dose treatment through DEC-medicated common salt. Diethylcarbamazine-medicated salt played a major role in the Chinese filariasis control program and has been successful in more limited trials in India, Brazil, and Tanzania. It is not being used today in any endemic area, but the evidence suggests that it is safe, effective, and relatively inexpensive. Enough is already known about the beneficial effects of DEC-medicated salt from community-wide studies to develop specific guidelines for its use in community programs.

PubMed: 8024057


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Diethylcarbamazine salt in the control of lymphatic filariasis.</title>
<author>
<name sortKey="Gelband, H" sort="Gelband, H" uniqKey="Gelband H" first="H" last="Gelband">H. Gelband</name>
<affiliation>
<nlm:affiliation>Office of Technology Assessment, U.S. Congress, Washington, District of Columbia.</nlm:affiliation>
<wicri:noCountry code="subField">District of Columbia</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1994">1994</date>
<idno type="RBID">pubmed:8024057</idno>
<idno type="pmid">8024057</idno>
<idno type="wicri:Area/PubMed/Corpus">005539</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005539</idno>
<idno type="wicri:Area/PubMed/Curation">005539</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005539</idno>
<idno type="wicri:Area/PubMed/Checkpoint">005539</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005539</idno>
<idno type="wicri:Area/Ncbi/Merge">00B363</idno>
<idno type="wicri:Area/Ncbi/Curation">00B363</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">00B363</idno>
<idno type="wicri:doubleKey">0002-9637:1994:Gelband H:diethylcarbamazine:salt:in</idno>
<idno type="wicri:Area/Main/Merge">00D222</idno>
<idno type="wicri:Area/Main/Curation">00C856</idno>
<idno type="wicri:Area/Main/Exploration">00C856</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Diethylcarbamazine salt in the control of lymphatic filariasis.</title>
<author>
<name sortKey="Gelband, H" sort="Gelband, H" uniqKey="Gelband H" first="H" last="Gelband">H. Gelband</name>
<affiliation>
<nlm:affiliation>Office of Technology Assessment, U.S. Congress, Washington, District of Columbia.</nlm:affiliation>
<wicri:noCountry code="subField">District of Columbia</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The American journal of tropical medicine and hygiene</title>
<idno type="ISSN">0002-9637</idno>
<imprint>
<date when="1994" type="published">1994</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Brugia malayi</term>
<term>China</term>
<term>Diethylcarbamazine (therapeutic use)</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Elephantiasis, Filarial (prevention & control)</term>
<term>Humans</term>
<term>India</term>
<term>Taiwan</term>
<term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Brugia malayi</term>
<term>Chine</term>
<term>Diéthylcarbamazine (usage thérapeutique)</term>
<term>Filariose lymphatique ()</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Humains</term>
<term>Inde</term>
<term>Taïwan</term>
<term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Diethylcarbamazine</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>China</term>
<term>India</term>
<term>Taiwan</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Diéthylcarbamazine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Brugia malayi</term>
<term>Humans</term>
<term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Brugia malayi</term>
<term>Chine</term>
<term>Filariose lymphatique</term>
<term>Humains</term>
<term>Inde</term>
<term>Taïwan</term>
<term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>République populaire de Chine</term>
<term>Inde</term>
<term>Taïwan</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Where lymphatic filariasis has diminished since about the 1950s, it has most frequently, though not always, been a direct result of chemotherapeutic intervention against the parasite. Diethylcarbamazine (DEC), a well-established drug, has been the single agent of chemotherapeutic control and has been successful in a wide variety of regimens. This paper reviews the experience with one strategy: long-term, low-dose treatment through DEC-medicated common salt. Diethylcarbamazine-medicated salt played a major role in the Chinese filariasis control program and has been successful in more limited trials in India, Brazil, and Tanzania. It is not being used today in any endemic area, but the evidence suggests that it is safe, effective, and relatively inexpensive. Enough is already known about the beneficial effects of DEC-medicated salt from community-wide studies to develop specific guidelines for its use in community programs.</div>
</front>
</TEI>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Gelband, H" sort="Gelband, H" uniqKey="Gelband H" first="H" last="Gelband">H. Gelband</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00C856 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00C856 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:8024057
   |texte=   Diethylcarbamazine salt in the control of lymphatic filariasis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:8024057" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024